DNA Ligase IV Antibodies

Santa Cruz Biotechnology provides a broad selection of DNA Ligase IV monoclonal antibodies for research in DNA repair and recombination processes. DNA Ligase IV monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DNA Ligase IV plays a vital role in the non-homologous end joining (NHEJ) pathway, which repairs double-strand breaks in DNA. DNA Ligase IV maintains genomic stability and participates in V(D)J recombination and the repair of DNA damage caused by ionizing radiation. Research focusing on DNA Ligase IV contributes significantly to understanding cancer biology and developing therapeutic interventions. Scientists worldwide utilize DNA Ligase IV monoclonal antibodies to advance their studies in DNA repair mechanisms. Ongoing research with DNA Ligase IV monoclonal antibodies continues to reveal new insights into cellular repair processes. Understanding DNA Ligase IV function helps researchers develop novel therapeutic strategies for DNA repair-related disorders. Santa Cruz Biotechnology monoclonal antibodies for DNA Ligase IV support researchers in making meaningful contributions to scientific advancement in DNA repair and cancer research.